your badges 52W Range $27–$59 85% of range Analyst Rating BUY 14 analysts Price Target $70 +28% upside P/E 19.8 ROE 100.3% Net Profit Margin 55.2%

TGTX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $54.29
Market Cap (MRQ) $8.31B
P/E (TTM) 19.8
EPS (TTM) $2.74
Revenue (TTM) $800M
ROE (TTM) 100.3%
Debt/Equity (MRQ) 1.2
52W Range $27–$59

TGTX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 2
Ex-date Split Type
April 30, 2012 1-for-56 Reverse
July 14, 2011 1-for-50 Reverse

About TG Therapeutics, Inc. - Common Stock Company overview from Wikipedia

05 · wikidata
sectorHealthcare industryBiotechnology employees399 countryUS

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$616M
2016-12-31 → 2025-12-31
EPS$2.77
2020-12-31 → 2025-12-31
Free Cash Flow$-25M
2017-12-31 → 2025-12-31
Net margin55.2%
2020-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend TGTX 5Y avg Peer Median Verdict
P/E (TTM) 19.85Y avg ≈77.4 ≈77.4 15.3 Overvalued
P/S (TTM) 10.45Y avg ≈262.6 ≈262.6 41.9 Undervalued
P/B (MRQ) 13.85Y avg ≈17.3 ≈17.3 8.5 Overvalued
EV / EBITDA (TTM) 62.35Y avg ≈33.2 ≈33.2 · ·
Price / FCF (TTM) 478.05Y avg ≈-80.0 ≈-80.0 · ·
Price / Cash Flow (TTM) 464.95Y avg ≈-80.4 ≈-80.4 · ·
EV / Revenue (TTM) 10.65Y avg ≈245.3 ≈245.3 · ·
EV / FCF (TTM) 489.15Y avg ≈-80.3 ≈-80.3 · ·
Price / Tangible Book 13.05Y avg ≈17.2 ≈17.2 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -53.7%
Next Report Nov 02, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 3, 2026 $0.05 $0.34 -85.5%
March 31, 2026 May 11, 2026 $0.18 $0.30 -40.1%
Dec. 31, 2025 $0.14 $0.36 -60.9%
Sept. 30, 2025 $0.16 $0.22 -28.7%
June 30, 2025 $0.17 $0.22 -23.3%
March 31, 2025 $0.03 $0.19 -83.8%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 16
Metric Trend 2025202420232022202120202019201820172016
Revenue $616M$329M$234M$3M$7M$152.0K$152.0K$152.0K$152.0K$152.0K
Cost of Revenue $101M$38M$14M$265.0K$790.0K·····
R&D Expense $160M$94M$76M$125M$223M$166M$154M$159M$103M$69M
SG&A Expense $232M$154M$123M$95M$128M$108M$15M$15M$16M$10M
Operating Expenses $493M$287M$213M$221M$351M$274M$169M$175M$119M$79M
Operating Income $123M$42M$21M$-218M$-345M$-274M$-169M$-174M$-119M$-79M
Interest Expense ··$13M$10M$6M$6M$5M$877.0K$845.0K·
Other Non-op $11M$8M$5M$5M$2M$-6M$-4M$918.0K$236.0K$716.0K
Pretax Income $107M$26M$13M$-224M$-348M$-279.4K$-172.9K$-173.5K$-118.5K$-78M
Income Tax $-340M$2M$390.0K$0$0$0$0$0$0$0
Net Income $447M$23M$13M$-224M$-348M$-279M$-173M$-173M··
EPS (Basic) $3.10$0.16$0.09$-1.65$-2.63$-2.42····
EPS (Diluted) $2.77$0.15$0.09$-1.65$-2.63$-2.42····
Shares (Basic) 144,316,786145,317,418141,955,112135,411,258132,222,753115,333,693····
Shares (Diluted) 161,412,746160,336,051148,508,465135,411,258132,222,753115,333,693····
EBITDA $123M$42M·$-193M$-345M$-274M$-169M$-174M$-119M·
Balance Sheet 25
Metric Trend 2025202420232022202120202019201820172016
Cash & Equivalents $79M$180M$93M$102M$299M$553M$113M$42M$57M$25M
Short-term Investments $63M$131M$125M$59M$16M$52M$28M$27M$28M$20M
Receivables $306M$129M$51M$0$1M·····
Inventory $126M$110M$40M$0······
Other Current Assets $58M$16M$10M$2M$3M$1M$611.0K$439.0K$437.0K$216.4K
Current Assets $631M$566M$318M$168M$331M$612M$149M$79M$93M$51M
PP&E (Net) ··$95.0K$307.0K$600.0K$481.0K$282.0K$251.0K$248.0K$328.1K
Goodwill ··$799.0K$799.0K$799.0K$799.0K$799.0K$799.0K$799.0K$799.4K
Other Non-current Assets $2M$2M$2M·····$0$164.4K
Total Assets $1.06B$578M$330M$194M$380M$626M$163M$84M$97M$55M
Accounts Payable $108M$58M$38M$42M$51M$37M$30M$36M$26M$15M
Short-term Debt ·····$938.0K$190.0K$67.0K$128.0K$68.9K
Current Liabilities $154M$91M$54M$53M$65M$88M$84M$39M$28M$17M
Capital Leases $7M$8M$9M$10M$10M$10M$10M$0··
Other Non-current Liabilities ······$0$18M$0·
Total Liabilities $415M$355M$169M$135M$142M$106M$124M$60M$30M$19M
Long-term Debt ··$100M$71M$68M$30M$29M···
Total Debt $246M$244M·$71M$68M$31M$29M$67.0K$127.6K·
Common Stock $159.0K$156.0K$151.0K$146.0K$143.0K$141.0K$109.0K$84.0K$73.0K$56.8K
Paid-in Capital $1.83B$1.76B$1.71B$1.59B$1.57B$1.50B$740M$553M$422M$272M
Retained Earnings $-1.08B$-1.53B$-1.55B$-1.53B$-1.33B$-981M$-701M$-528M$-355M$-236M
Treasury Stock $100M$9M$234.0K$234.0K$234.0K$234.0K$234.0K$234.0K$234.0K$234.0K
Stockholders' Equity $648M$222M$161M$59M$237M$519M$39M$24M$67M$36M
Liabilities + Equity $1.06B$578M$330M$194M$380M$626M$163M$84M$97M$55M
Shares Outstanding 155,305,953155,836,256151,424,289146,385,388143,250,734140,576,297109,383,93483,870,54673,140,44156,779,114
Cash Flow 15
Metric Trend 2025202420232022202120202019201820172016
D&A $59.0K$68.0K$211.0K$303.0K$282.0K·····
Stock-based Comp $65M$43M$38M$45M$61M$80M$11M$13M$16M$8M
Deferred Tax $-348M$0$0··$0$0···
Amort. of Intangibles ···$212.0K$212.0K$216.0K$182.0K···
Other Non-cash $-189M$-107M········
Operating Cash Flow $-25M$-41M$-31M$-176M$-296M$-215M$-133M$-129M$-94M$-62M
CapEx $214.0K$45.0K$0$14.0K$401.0K$357.0K$131.0K$90.0K$2.0K$344.0K
Investing Cash Flow $14M$-1M$-51M$-20M$-332.0K$-25M$-718.0K$1M$-8M·
Stock Issued $0$0$46M$0$2M·····
Net Stock Activity $0·········
Financing Cash Flow $-90M$129M$73M$-391.0K$41M$680M$204M$114M$134M·
Net Change in Cash $-101M$87M$-9M$-197M$-255M$441M$71M$-14M$32M$-30M
Taxes Paid $8M$500.0K$0$0······
Free Cash Flow $-25M$-41M·$-176M$-296M$-215M$-133M$-129M$-94M·
Levered FCF ···$-186M$-302M$-221M$-138M···
Profitability 7
Metric Trend 2025202420232022202120202019201820172016
Operating Margin 20.0%12.7%·-6924.2%-5154.3%-179996.0%-111220.4%-114736.8%··
Net Margin 72.6%7.1%·-7121.5%-5204.1%-183803.3%····
Pretax Margin 17.4%7.8%·-7121.5%-5204.1%-183803.3%-113730.9%-114132.9%··
EBITDA Margin 20.0%12.8%·-6924.2%-5154.3%-179996.0%-111220.4%-114736.8%··
ROA 54.5%5.1%·-69.2%-69.3%-70.9%····
ROE 96.7%11.3%·-249.4%-126.9%-81.0%····
ROIC 57.5%8.2%·-148.7%-113.1%-49.7%-249.4%-723.6%-176.9%·
Liquidity & Solvency 5
Metric Trend 2025202420232022202120202019201820172016
Current Ratio 4.16.2·3.25.17.01.82.03.3·
Quick Ratio 2.94.9·3.04.86.91.71.83.0·
Debt / Equity 0.41.1·1.20.30.10.80.00.0·
LT Debt / Equity 0.41.1·1.20.30.00.8···
Interest Coverage ···-18.9-61.2-43.2-32.0···
Efficiency 3
Metric Trend 2025202420232022202120202019201820172016
Asset Turnover 0.80.7·0.00.00.00.00.0··
Inventory Turnover 0.90.5········
Receivables Turnover 2.83.6··9.6·····
Per Share 5
Metric Trend 2025202420232022202120202019201820172016
Book Value / Share $4.17$1.43·$0.40$1.66$3.69$0.35$0.29$0.92·
Revenue / Share $3.82$2.05·$0.02······
Cash Flow / Share $-0.15$-0.25·$-1.30······
Cash / Share $0.51$1.15·$0.70$2.09$3.94$1.03$0.50$0.78·
EPS (TTM) $2.77$0.15$0.09$-1.65$-2.63$-2.42····
Growth Rates 5
Metric Trend 2025202420232022202120202019201820172016
Revenue YoY 87.3%40.8%8290.0%-58.4%4300.7%·····
Revenue CAGR 3Y 504.9%266.4%1054.1%·······
Revenue CAGR 5Y 426.7%·········
EPS YoY 1746.7%66.7%········
Net Income YoY 1812.4%84.5%········
Valuation (TTM) 14
Metric Trend 2025202420232022202120202019201820172016
Revenue TTM $616M$329M$234M$3M$7M$152.0K$152.0K$152.0K$152.0K$152.0K
Net Income TTM $447M$23M$13M$-224M$-348M$-279M$-173M$-173M$-118M$-78M
Market Cap $4.63B$4.69B·$1.73B$2.72B$7.31B$1.21B$344M$600M·
Enterprise Value $4.73B$4.62B·$1.64B$2.47B$6.74B$1.10B$275M$515M·
P/E 10.8200.7189.8-7.2-7.2-21.5····
P/S 7.514.3·621.8406.948110.47987.92262.33945.7·
P/B 7.121.1·29.611.514.131.414.39.0·
P / Tangible Book 7.121.116.230.011.514.1····
P / Cash Flow -186.9-115.8·-9.8-9.2-34.1-9.1-2.7-6.4·
P / FCF -185.3-115.6·-9.8-9.2-34.0-9.1-2.7-6.4·
EV / EBITDA 38.4110.1·-8.5-7.2-24.6-6.5-1.6-4.3·
EV / FCF -189.4-114.0·-9.3-8.4-31.4-8.3-2.1-5.5·
EV / Revenue 7.714.1·589.3370.044330.27255.81810.13389.2·
Earnings Yield 9.3%0.50%0.53%-14.0%-13.8%-4.7%····

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $616M $329M $234M $3M $7M
Operating Margin % 20.0% 12.7% · -6924.2% -5154.3%
Net Income $447M $23M $13M $-224M $-348M
Diluted EPS $2.77 $0.15 $0.09 $-1.65 $-2.63

Institutional owners (13F) 482 filers · $6.6B total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 482
Value held $6.6B
New positions 116
Exited positions 32
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
116 (+35 vs prior Q) 32 (-12 vs prior Q) 155 (+22 vs prior Q) 127 (+13 vs prior Q) +6.2M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
BlackRock, Inc. $1,211,429,475 22,050,045 18.40% Shares
VANGUARD GROUP INC $472,220,271 15,841,002 7.17% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $437,501,834 7,963,266 6.65% Shares
STATE STREET CORP $427,788,717 7,786,471 6.50% Shares
VANGUARD CAPITAL MANAGEMENT LLC $337,848,201 6,149,403 5.13% Shares
GEODE CAPITAL MANAGEMENT, LLC $200,135,578 3,642,216 3.04% Shares
D. E. Shaw & Co., Inc. $186,840,392 3,400,808 2.84% Shares
Soleus Capital Management, L.P. $160,858,551 2,927,895 2.44% Shares
Clearbridge Investments, LLC $145,601,554 2,650,192 2.21% Shares
CONGRESS ASSET MANAGEMENT CO $142,850,758 2,600,123 2.17% Shares
TWO SIGMA INVESTMENTS, LP $135,645,267 2,468,971 2.06% Shares
GOLDMAN SACHS GROUP INC $127,146,488 2,314,279 1.93% Shares
Pictet Asset Management Holding SA $98,120,148 1,785,951 1.49% Shares
JANE STREET GROUP, LLC $96,290,371 1,752,646 1.46% Shares
Nuveen, LLC $89,325,628 1,625,876 1.36% Shares
MORGAN STANLEY $87,998,254 1,601,714 1.34% Shares
Hood River Capital Management LLC $87,932,019 1,600,510 1.34% Shares
NORTHERN TRUST CORP $84,446,021 1,537,059 1.28% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $74,762,352 1,360,800 1.14% Call option
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $72,141,879 1,313,103 1.10% Shares
BANK OF AMERICA CORP /DE/ $71,959,753 1,309,788 1.09% Shares
DIMENSIONAL FUND ADVISORS LP $66,512,573 1,210,578 1.01% Shares
FMR LLC $55,973,620 1,018,814 0.85% Shares
VANGUARD FIDUCIARY TRUST CO $52,838,545 961,750 0.80% Shares
BARCLAYS PLC $52,624,168 957,848 0.80% Shares
Bank of New York Mellon Corp $49,472,499 900,482 0.75% Shares
BNP PARIBAS FINANCIAL MARKETS $47,275,870 860,500 0.72% Shares
VOYA INVESTMENT MANAGEMENT LLC $45,009,760 819,253 0.68% Shares
Woodline Partners LP $39,309,570 715,500 0.60% Shares
RENAISSANCE TECHNOLOGIES LLC $37,320,742 679,300 0.57% Shares
PRINCIPAL FINANCIAL GROUP INC $35,455,035 645,341 0.54% Shares
RAYMOND JAMES FINANCIAL INC $34,078,122 620,280 0.52% Shares
CITADEL ADVISORS LLC $29,512,119 537,170 0.45% Shares
Penn Capital Management Company, LLC $29,505,770 536,067 0.45% Shares
Opaleye Management Inc. $29,392,900 535,000 0.45% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $28,876,464 525,600 0.44% Put option
BANK OF MONTREAL /CAN/ $28,347,995 515,981 0.43% Shares
UBS Group AG $28,303,000 515,162 0.43% Shares
WELLINGTON MANAGEMENT GROUP LLP $26,275,879 478,265 0.40% Shares
Public Sector Pension Investment Board $24,877,766 452,817 0.38% Shares
AQR CAPITAL MANAGEMENT LLC $24,299,247 442,287 0.37% Shares
Bridgewater Associates, LP $23,618,926 429,904 0.36% Shares
JPMORGAN CHASE & CO $23,079,278 407,499 0.35% Shares
Occam Crest Management LP $22,729,000 425,000 0.35% Shares
NEW YORK STATE COMMON RETIREMENT FUND $22,429,530 408,255 0.34% Shares
Invesco Ltd. $22,352,832 406,859 0.34% Shares
683 Capital Management, LLC $21,376,111 389,081 0.32% Shares
CITIGROUP INC $21,321,500 388,087 0.32% Shares
CITADEL ADVISORS LLC $20,970,598 381,700 0.32% Call option
WELLS FARGO & COMPANY/MN $20,651,604 375,894 0.31% Shares

Show all 482 institutional owners →

Activists & 5%+ owners 6 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
LFB Biotechnologies, S.A.S.U. ×2 filings July 11, 2018 · Initial filing · SEC
LFB Biotechnologies, S.A.S. ×2 filings May 11, 2015 · Initial filing Board campaign SEC
Opus Point Partners, LLC*, Michael S. Weiss* ×3 filings Aug. 28, 2012 · Initial filing · SEC
Nordic Biotech Venture Fund II K/S (2), Nordic Biotech General Partner II (2), Christian Hansen (2), Florian Schönharting (2) ×3 filings Jan. 24, 2011 · Initial filing · SEC
Undisclosed reporting person March 5, 2008 · Initial filing · SEC
Lester E. Lipschutz April 8, 2005 · Initial filing M&A / sale SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 26 insiders · 4 officers · 17 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Michael S Weiss CEO Jan. 8, 2026 A 9,778,086 0 0 $0
Sean A Power CFO Jan. 8, 2026 A 798,111 0 0 $0
Michael Mcguinness COO & CFO March 3, 2010 A 10,000 0 0 $0
Alan G Harris Chief Medical Officer April 25, 2007 A · 0 0 $0
Laurence N Charney Director Sept. 10, 2026 S 168,640 0 1 $-274,800
Sagar Lonial Director June 11, 2026 A 94,061 0 0 $0
Daniel Hume Director June 11, 2026 A 192,748 0 0 $0
Kenneth Hoberman Director June 11, 2026 A 279,653 0 0 $0
Yann Echelard Director June 11, 2026 A 223,816 0 1 $-162,850
William James Kennedy Director June 22, 2020 A 109,633 0 0 $0
Mark Schoenebaum Director June 26, 2018 A 125,949 0 0 $0
Neil Herskowitz Director June 6, 2014 A 80,088 0 0 $0
David Shimko Director March 18, 2010 A · 0 0 $0
Douglas Abel Director March 3, 2010 A 45,000 0 0 $0
Richard I Steinhart Director March 3, 2010 A 5,633 0 0 $0
Timothy Mcinerney Director March 3, 2010 A 674,007 0 0 $0
Joan Pons Gimbert Director Jan. 30, 2007 A 2,112 0 0 $0
Joshua A Kazam Director April 1, 2005 A 492,852 0 0 $0
David M Tanen Director April 1, 2005 A 602,517 0 0 $0
Leonard Mc Firestone Director Jan. 28, 2004 A · 0 0 $0
LFB Biotechnologies S.A.S.U. 10% owner May 7, 2015 X 7,614,855 0 0 $0
Lindsay A. Rosenwald, M.D. 10% owner April 1, 2005 P 2,564,321 0 0 $0
Jay J Lobell 10% owner Nov. 7, 2003 P · 0 0 $0
Malcolm Hoenlein · March 3, 2010 A 4,861 0 0 $0
Michael Weiser · March 3, 2010 A 2,292,241 0 0 $0
Nicholas J Rossettos · Jan. 11, 2005 A · 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 53 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
PSCH · Invesco Exchange-Traded Fund Trust … 4.16% 134,914 SH Oct. 2, 2026 Daily
PBE · Invesco Exchange-Traded Fund Trust 2.74% 211,736 SH Oct. 2, 2026 Daily
BBP · ETFis Series Trust I 1.45% 27,407 NS July 31, 2026 N-PORT
XSHQ · Invesco Exchange-Traded Fund Trust … 1.33% 71,724 SH Oct. 2, 2026 Daily
RZG · Invesco Exchange-Traded Fund Trust 1.31% 29,202 SH Oct. 2, 2026 Daily
VIOG · VANGUARD ADMIRAL FUNDS 0.79% 156,885 SH Aug. 19, 2026 Daily
LABU · Direxion Shares ETF Trust 0.76% 72,380 NS July 31, 2026 N-PORT
FNY · First Trust Exchange-Traded AlphaDE… 0.75% 83,533 NS July 31, 2026 N-PORT
IWO · iShares Trust 0.53% 1,371,071 SH Sept. 11, 2026 Daily
VTWG · VANGUARD SCOTTSDALE FUNDS 0.47% 155,880 SH Aug. 19, 2026 Daily
JSML · Janus Detroit Street Trust 0.45% 31,538 NS July 31, 2026 N-PORT
QVMS · Invesco Exchange-Traded Fund Trust … 0.45% 19,763 SH Oct. 2, 2026 Daily
SAWS · ETF Series Solutions 0.44% 661 NS July 31, 2026 N-PORT
VIOO · VANGUARD ADMIRAL FUNDS 0.39% 460,826 SH Aug. 19, 2026 Daily
FNX · First Trust Exchange-Traded AlphaDE… 0.35% 93,741 NS July 31, 2026 N-PORT
BKSE · BNY Mellon ETF Trust 0.33% 5,618 NS July 31, 2026 N-PORT
SMDX · Tidal Trust III 0.29% 7,270 NS July 31, 2026 N-PORT
IWM · iShares Trust 0.26% 3,718,128 SH Sept. 11, 2026 Daily
ISCG · iShares Trust 0.26% 45,748 SH Sept. 11, 2026 Daily
RSSL · Global X Funds 0.24% 69,705 NS July 31, 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.24% 837,766 SH Aug. 19, 2026 Daily
FAD · First Trust Exchange-Traded AlphaDE… 0.23% 25,080 NS July 31, 2026 N-PORT
PWS · Pacer Funds Trust 0.21% 989 NS July 31, 2026 N-PORT
VBK · VANGUARD INDEX FUNDS 0.21% 1,825,086 SH Aug. 19, 2026 Daily
BBMC · J.P. Morgan Exchange-Traded Fund Tr… 0.16% 63,125 NS July 31, 2026 N-PORT
OMFS · Invesco Exchange-Traded Self-Indexe… 0.12% 6,015 SH Oct. 2, 2026 Daily
VHT · VANGUARD WORLD FUND 0.12% 443,566 SH Aug. 19, 2026 Daily
FHLC · FIDELITY COVINGTON TRUST 0.11% 70,188 NS July 31, 2026 N-PORT
ESML · iShares Trust 0.09% 46,641 SH Sept. 11, 2026 Daily
VB · VANGUARD INDEX FUNDS 0.09% 3,160,081 SH Aug. 19, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.08% 1,511,242 SH Aug. 19, 2026 Daily
PRFZ · Invesco Exchange-Traded Fund Trust 0.08% 38,560 SH Oct. 2, 2026 Daily
WSML · iShares Trust 0.08% 9,086 SH Sept. 11, 2026 Daily
DFAS · Dimensional ETF Trust 0.07% 218,809 NS July 31, 2026 N-PORT
RWJ · Invesco Exchange-Traded Fund Trust … 0.05% 18,554 SH Oct. 2, 2026 Daily
TILT · FlexShares Trust 0.01% 5,184 NS July 31, 2026 N-PORT
IWV · iShares Trust 0.01% 41,229 SH Sept. 11, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.01% 4,377,871 SH Aug. 19, 2026 Daily
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0.01% 117,931 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.01% 11,892 SH Aug. 19, 2026 Daily
ITOT · iShares Trust 0.01% 172,317 SH Sept. 11, 2026 Daily
DFAU · Dimensional ETF Trust 0.01% 23,974 NS July 31, 2026 N-PORT
ESGV · VANGUARD WORLD FUND 0.01% 32,154 SH Aug. 19, 2026 Daily
DFAC · Dimensional ETF Trust 0.01% 61,852 NS July 31, 2026 N-PORT
DFUS · Dimensional ETF Trust 0.01% 21,652 NS July 31, 2026 N-PORT
DCOR · Dimensional ETF Trust 0.00% 288 NS July 31, 2026 N-PORT
DFSU · Dimensional ETF Trust 0.00% 19 NS July 31, 2026 N-PORT
IJR · iShares Trust · 8,038,433 SH Sept. 10, 2026 Daily
IJT · iShares Trust · 1,246,927 SH Sept. 9, 2026 Daily
XJR · iShares Trust · 18,207 SH Aug. 31, 2026 Daily
ISCB · iShares Trust · 6,486 SH Sept. 11, 2026 Daily
SMLF · iShares Trust · 70,058 SH Sept. 11, 2026 Daily
SMMV · iShares Trust · 2,812 SH Sept. 1, 2026 Daily

TGTX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 14 analysts BUY
Median target $75.00 +38.1%
3 21.4% Strong Buy
9 64.3% Buy
1 7.1% Hold
1 7.1% Sell
0 0.0% Strong Sell

12-Month Price Target

7 analysts · 2026-09-29

Mean target $69.71 +28.4%

Now Current price $54.29
Low$21.00 Mean$69.71 High$86.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
TGTX $4.63B 10.8 87.3% 72.6% 96.7% ·
ARWR $4.68B -3449.0 23258.2% -0.20% -0.50% ·
PTGX $5.47B -42.6 -89.4% -282.8% -20.3% ·
KYMR $6.33B -21.1 -16.7% -794.0% -24.4% ·
PCVX $6.05B -8.2 · · -26.6% ·
PRAX $7.43B -21.9 249.5% · -47.3% ·
SYRE $2.56B 10.1 -62.0% · -26.5% ·
CAI $7.62B -8.4 97.0% -8.4% -13.2% ·
IONS $12.92B -33.2 · · -68.1% ·

Latest News Recent headlines mentioning this company

23
Signal Says Which Biotech to Buy This Week Yahoo Finance · 4 months, 3 weeks ago This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid 30% Stock Drop Yahoo Finance · 6 months, 2 weeks ago

Trading Signals Recent buy/sell signals with entry price and risk/reward ratio

25
BLUECHIP_DIP Stopped out Aug 6
risk 1 reward 2.78
entry $49.88 R:R 2.78
BOUNCE_UP Expired Nov 10
risk 1 reward 1.50
entry $30.52 R:R 1.50

No open signal right now — no card is filled, and that's honest.

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 5, 2026